Cardiovascular profile of loratadine.

Cardiovascular profile of loratadine.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (1999-08-12)

J A Hey, M Affrime, B Cobert, W Kreutner, F M Cuss

要旨

The extremely low reporting rate of cardiovascular adverse events for loratadine, the possible preferential use of loratadine in patients with pre-existing cardiovascular disorders, and the impressive lack of cardiovascular effects at extremely high concentrations in clinical and preclinical studies demonstrate the very safe cardiovascular profile of loratadine.

材料

製品番号

ブランド

製品内容

L9664

Sigma-Aldrich

ロラタジン, ≥98% (HPLC), powder

1370270

USP

ロラタジン, United States Pharmacopeia (USP) Reference Standard

PHR1376

Supelco

ロラタジン, Pharmaceutical Secondary Standard; Certified Reference Material

Y0000603

システム適合性用ロラタジン, European Pharmacopoeia (EP) Reference Standard

Y0000688

ロラタジン, European Pharmacopoeia (EP) Reference Standard